Matches in Nanopublications for { ?s ?p "[Moreover, several tumour suppressors and oncogenes have been shown to be involved in melanoma pathogenesis, including CDKN2A, PTEN, TP53, RAS and MYC, but have not been related to melanoma subtypes or validated as prognostic markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP433453.RAM7C1mchuwx1QmMqWR9oezIdiCMAkgtCnoMBV_7yxeyQ130_assertion description "[Moreover, several tumour suppressors and oncogenes have been shown to be involved in melanoma pathogenesis, including CDKN2A, PTEN, TP53, RAS and MYC, but have not been related to melanoma subtypes or validated as prognostic markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433453.RAM7C1mchuwx1QmMqWR9oezIdiCMAkgtCnoMBV_7yxeyQ130_provenance.
- NP536003.RAbmZl3L79hhQ4jZApkpA5BM1o5c9TUneDbb-AKEpdlQo130_assertion description "[Moreover, several tumour suppressors and oncogenes have been shown to be involved in melanoma pathogenesis, including CDKN2A, PTEN, TP53, RAS and MYC, but have not been related to melanoma subtypes or validated as prognostic markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536003.RAbmZl3L79hhQ4jZApkpA5BM1o5c9TUneDbb-AKEpdlQo130_provenance.